Lamotrigine

Generic: Lamotrigine

Labeler: A-S Medication Solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Active

Drug Facts

Product Profile

Brand Name Lamotrigine
Generic Name Lamotrigine
Labeler A-S Medication Solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

LAMOTRIGINE 25 mg/1

Identifiers & Regulatory

Product NDC 50090-2129
Product ID 50090-2129_87156334-26f7-4310-913b-165cf3427518
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090170
Listing Expiration 2026-12-31
Marketing Start 2011-11-01

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500902129
Hyphenated Format 50090-2129

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name Lamotrigine (source: ndc)
Generic Name Lamotrigine (source: ndc)
Application Number ANDA090170 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (50090-2129-0)
  • 180 TABLET in 1 BOTTLE (50090-2129-1)
  • 30 TABLET in 1 BOTTLE (50090-2129-2)
source: ndc

Packages (3)

50090-2129-0 60 TABLET in 1 BOTTLE (50090-2129-0) 50090-2129-1 180 TABLET in 1 BOTTLE (50090-2129-1) 50090-2129-2 30 TABLET in 1 BOTTLE (50090-2129-2)

Ingredients (1)

LAMOTRIGINE (25 mg/1)

Linked Drug Pages (1)

Lamotrigine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "87156334-26f7-4310-913b-165cf3427518", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["198427", "198428", "282401"], "spl_set_id": ["6139a858-700c-4eb9-9f84-99d280bde326"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (50090-2129-0)", "package_ndc": "50090-2129-0", "marketing_start_date": "20151015"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (50090-2129-1)", "package_ndc": "50090-2129-1", "marketing_start_date": "20190925"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-2129-2)", "package_ndc": "50090-2129-2", "marketing_start_date": "20200122"}], "brand_name": "Lamotrigine", "product_id": "50090-2129_87156334-26f7-4310-913b-165cf3427518", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "50090-2129", "generic_name": "Lamotrigine", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "25 mg/1"}], "application_number": "ANDA090170", "marketing_category": "ANDA", "marketing_start_date": "20111101", "listing_expiration_date": "20261231"}